Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Cristina Medeiros-Ribeiro

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|June 9, 2026
Prospective evaluation of recombinant Herpes zoster vaccine in systemic sclerosis: immunogenicity, safety, and disease outcomesAna Paula Luppino-Assad, Renata P Mello, Ana Cristina Medeiros-Ribeiro, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|February 29, 2024
Rheumatoid arthritis-associated airway disease: longitudinal pulmonary function behaviorMaria Laura Bertozo Sabbag, Camila de Assis Molina, Márcio Valente Yamada Sawamura, et al.
Rheumatology (Oxford, England)|August 22, 2012
TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patientsIvan Leonardo Avelino França, Ana Cristina Medeiros Ribeiro, Nádia Emi Aikawa, et al.
Scandinavian Journal of Medicine & Science in Sports|July 18, 2022
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patientsBruno Gualano, Ítalo Ribeiro Lemes, Rafael Pires da Silva, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2024
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and TaperingClarissa Q Pimentel, Ana Cristina Medeiros-Ribeiro, Andrea Y Shimabuco, et al.
Rheumatology (Oxford, England)|December 11, 2021
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapyPercival Degrava Sampaio-Barros, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino-Assad, et al.
Annals of the Rheumatic Diseases|February 23, 2022
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trialCarlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, et al.
Arthritis Care & Research|November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus ErythematosusEmily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases|February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritisAna Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|June 9, 2026
Prospective evaluation of recombinant Herpes zoster vaccine in systemic sclerosis: immunogenicity, safety, and disease outcomesAna Paula Luppino-Assad, Renata P Mello, Ana Cristina Medeiros-Ribeiro, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|February 29, 2024
Rheumatoid arthritis-associated airway disease: longitudinal pulmonary function behaviorMaria Laura Bertozo Sabbag, Camila de Assis Molina, Márcio Valente Yamada Sawamura, et al.
Rheumatology (Oxford, England)|August 22, 2012
TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patientsIvan Leonardo Avelino França, Ana Cristina Medeiros Ribeiro, Nádia Emi Aikawa, et al.
Scandinavian Journal of Medicine & Science in Sports|July 18, 2022
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patientsBruno Gualano, Ítalo Ribeiro Lemes, Rafael Pires da Silva, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2024
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and TaperingClarissa Q Pimentel, Ana Cristina Medeiros-Ribeiro, Andrea Y Shimabuco, et al.
Rheumatology (Oxford, England)|December 11, 2021
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapyPercival Degrava Sampaio-Barros, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino-Assad, et al.
Annals of the Rheumatic Diseases|February 23, 2022
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trialCarlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, et al.
Arthritis Care & Research|November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus ErythematosusEmily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases|February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritisAna Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Pageof 3